Can you see the implications for Gender (Economics) in this story from the New York Times on India’s Efforts to Aid Poor Worry Drug Makers ?  The skirmishing over Herceptin and other cancer medicines is part of a long-running struggle to make drugs affordable to the world’s poorest people.

Is it that capitalist thinking of scarcity and power that causes this and could a balance in gendered thinking provide different solutions to the pharmaceutical industries dilemma?